Adilia Hormigo
Distinguished in Brain Tumor

Dr. Adilia Hormigo

Neurology
Montefiore Einstein
Montefiore Medical Park At Eastchester
1695 Eastchester Road, 
Bronx, NY 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Brain Tumor
Montefiore Einstein
Montefiore Medical Park At Eastchester
1695 Eastchester Road, 
Bronx, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Adilia Hormigo, MD, PhD, is Leader, Neuro-Oncology Program, Co-Leader, Neuro-Oncology Multidisciplinary Disease Team and Professor, Hematology-Oncology, Neurosurgery, and Microbiology & Immunology at Montefiore Einstein. She is also a member of the Cancer Therapeutics Program. Her clinical expertise is the treatment of malignancies of the central nervous system and neurologic complications of cancer.

Dr. Hormigo is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. Her top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Myringotomy.

Her clinical research consists of co-authoring 28 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 19 articles and participated in 1 clinical trial in the study of Brain Tumor.

Graduate Institution
Lisbon Medical School
Residency
New York Presbyterian Hospital
Specialties
Neurology
Licenses
Psychiatry & Neurology in NY
Fellowships
Memorial Sloan Kettering Cancer Center
Hospital Affiliations
Montefiore Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Archcare
  • MEDICARE SNP
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
CenterLight Healthcare
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Hamaspik
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Longevity Health Plan
  • MEDICARE SNP
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetroPlus Health
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
MVP Health
  • EPO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Senior Whole Health
  • MEDICARE-MEDICAID PLAN
The Wellness Plan Medical Centers
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VNS Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Montefiore Medical Park at Eastchester
1695 Eastchester Road, Bronx, NY 10461
Call: 718-405-8505
Other Locations
Montefiore Einstein Advanced Care -Westchester
555 Taxter Road, Elmsford, NY 10523
Call: 914-457-4130

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway Mutations
Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK Pathway Mutations
Enrollment Status: Recruiting
Publish Date: January 12, 2026
Intervention Type: Drug
Study Drugs: Vismodegib, GSK2256098, Capivasertib, Abemaciclib
Study Phase: Phase 2
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation
Enrollment Status: Active_not_recruiting
Publish Date: November 28, 2025
Intervention Type: Other, Drug
Study Drugs: Temozolomide, Veliparib
Study Phase: Phase 2/Phase 3
Phase I Study of Tumor Treatment Fields and a Personalized Mutation-derived Tumor Vaccine in Patients With Newly Diagnosed Glioblastoma (GCO 17-0566)
Phase I Study of Tumor Treatment Fields and a Personalized Mutation-derived Tumor Vaccine in Patients With Newly Diagnosed Glioblastoma (GCO 17-0566)
Enrollment Status: Active_not_recruiting
Publish Date: September 10, 2025
Intervention Type: Biological, Drug, Device
Study Drugs: Poly-ICLC, Peptides
Study Phase: Phase 1
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
Enrollment Status: Suspended
Publish Date: April 03, 2024
Intervention Type: Biological
Study Phase: Phase 3
Phase I Study of PD-L1 Inhibition With Avelumab and Laser Interstitial Thermal Therapy in Patients With Recurrent Glioblastoma
Phase I Study of PD-L1 Inhibition With Avelumab and Laser Interstitial Thermal Therapy in Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: January 04, 2022
Intervention Type: Combination product, Drug
Study Drugs: Avelumab, MRI-guided LITT therapy
Study Phase: Phase 1
A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma
A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma
Enrollment Status: Withdrawn
Publish Date: January 13, 2020
Intervention Type: Drug, Biological
Study Phase: Phase 2
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: October 23, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

28 Total Publications

Multiparametric Radiogenomic Model to Predict Survival in Patients with Glioblastoma.
Multiparametric Radiogenomic Model to Predict Survival in Patients with Glioblastoma.
Journal: Cancers
Published: January 08, 2024
View All 28 Publications
Similar Doctors
Elite in Brain Tumor
Dr. Andrew B. Lassman
Neurology
Elite in Brain Tumor
Dr. Andrew B. Lassman
Neurology

Trustees Of Columbia University In The City Of New York

51 W 51st St, 
New York, NY 
 (9.8 miles away)
212-326-5705
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Andrew Lassman is a Neurologist in New York, New York. Dr. Lassman is rated as an Elite provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri.

Elite in Brain Tumor
Dr. Fabio M. Iwamoto
Neurology
Elite in Brain Tumor
Dr. Fabio M. Iwamoto
Neurology

Trustees Of Columbia University In The City Of New York

710 W 168th St, 
New York, NY 
 (4.2 miles away)
212-305-3870
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Fabio Iwamoto is a Neurologist in New York, New York. Dr. Iwamoto is rated as an Elite provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Elite in Brain Tumor
Dr. Thomas J. Kaley
Neurology
Elite in Brain Tumor
Dr. Thomas J. Kaley
Neurology

Memorial Neurology Group

1275 York Ave, 
New York, NY 
 (9.0 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Thomas Kaley is a Neurologist in New York, New York. Dr. Kaley is rated as an Elite provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Astrocytoma, Meningioma, Glioblastoma, and Glioma.

VIEW MORE BRAIN TUMOR DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hormigo's expertise for a condition
ConditionClose
  • Elite
  • Astrocytoma
    Dr. Hormigo is
    Elite
    . Learn about Astrocytoma.
    See more Astrocytoma experts
  • Glioblastoma
    Dr. Hormigo is
    Elite
    . Learn about Glioblastoma.
    See more Glioblastoma experts
  • Glioma
    Dr. Hormigo is
    Elite
    . Learn about Glioma.
    See more Glioma experts
  • Distinguished
  • Atypical Teratoid Rhabdoid Tumor (ATRT)
    Dr. Hormigo is
    Distinguished
    . Learn about Atypical Teratoid Rhabdoid Tumor (ATRT).
    See more Atypical Teratoid Rhabdoid Tumor (ATRT) experts
  • Brain Tumor
    Dr. Hormigo is
    Distinguished
    . Learn about Brain Tumor.
    See more Brain Tumor experts
  • Embryonal Tumor with Multilayered Rosettes
    Dr. Hormigo is
    Distinguished
    . Learn about Embryonal Tumor with Multilayered Rosettes.
    See more Embryonal Tumor with Multilayered Rosettes experts
  • Gliomatosis Cerebri
    Dr. Hormigo is
    Distinguished
    . Learn about Gliomatosis Cerebri.
    See more Gliomatosis Cerebri experts
  • Gliosarcoma
    Dr. Hormigo is
    Distinguished
    . Learn about Gliosarcoma.
    See more Gliosarcoma experts
  • Neuroepithelioma
    Dr. Hormigo is
    Distinguished
    . Learn about Neuroepithelioma.
    See more Neuroepithelioma experts
View All 8 Distinguished Conditions
  • Advanced
  • Brain Stem Cancer
    Dr. Hormigo is
    Advanced
    . Learn about Brain Stem Cancer.
    See more Brain Stem Cancer experts
  • Dysembryoplastic Neuroepithelial Tumors (DNET)
    Dr. Hormigo is
    Advanced
    . Learn about Dysembryoplastic Neuroepithelial Tumors (DNET).
    See more Dysembryoplastic Neuroepithelial Tumors (DNET) experts
  • Ependymoma
    Dr. Hormigo is
    Advanced
    . Learn about Ependymoma.
    See more Ependymoma experts
  • Melanoma
    Dr. Hormigo is
    Advanced
    . Learn about Melanoma.
    See more Melanoma experts
  • Metastatic Brain Tumor
    Dr. Hormigo is
    Advanced
    . Learn about Metastatic Brain Tumor.
    See more Metastatic Brain Tumor experts
  • Oligodendroglioma
    Dr. Hormigo is
    Advanced
    . Learn about Oligodendroglioma.
    See more Oligodendroglioma experts
View All 7 Advanced Conditions
  • Experienced
  • Adult T-Cell Leukemia
    Dr. Hormigo is
    Experienced
    . Learn about Adult T-Cell Leukemia.
    See more Adult T-Cell Leukemia experts
  • Angiosarcoma of the Scalp
    Dr. Hormigo is
    Experienced
    . Learn about Angiosarcoma of the Scalp.
    See more Angiosarcoma of the Scalp experts
  • Chronic T-Cell Leukemia (CTCL)
    Dr. Hormigo is
    Experienced
    . Learn about Chronic T-Cell Leukemia (CTCL).
    See more Chronic T-Cell Leukemia (CTCL) experts
  • Gaucher Disease
    Dr. Hormigo is
    Experienced
    . Learn about Gaucher Disease.
    See more Gaucher Disease experts
  • Gaucher Disease Type 1
    Dr. Hormigo is
    Experienced
    . Learn about Gaucher Disease Type 1.
    See more Gaucher Disease Type 1 experts
  • Gaucher Disease Type 2
    Dr. Hormigo is
    Experienced
    . Learn about Gaucher Disease Type 2.
    See more Gaucher Disease Type 2 experts
View All 16 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.